Home Endo to pay $25M for nasal testosterone replacement therapy
 

Keywords :   


Endo to pay $25M for nasal testosterone replacement therapy

2014-11-25 00:20:24| Biotech - Topix.net

Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million. Natesto is the only testosterone nasal gel approved by the Food and Drug Administration as a replacement therapy for adult males with hypogonadism - a condition where sex glands produce little or no sex hormones.

Tags: pay therapy replacement 25m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
13.05Dantex announces new digital director for Pico division
13.05Tonny De Beer Joins First Quality
13.05Join us for the 2024 Global Hog Industry Virtual Conference
13.05New version of Chat-GPT can teach maths and flirt
13.05Eastern North Pacific Tropical Weather Outlook
13.05Melinda French Gates to quit Gates Foundation
13.05BASF in South Carolina Joins with Make-A-Wish
13.05PCMC addresses latest printing trends at \'Power Packs Live\'
More »